SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 4368.80 millions for the September 2024 quarter. The mentioned figure indicates a growth of about 30.87% as compared to Rs. 3338.30 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 433.70 millions grew from Rs.-308.10 millionsOperating profit surged to 715.80 millions from the corresponding previous quarter of 2.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 4368.80 3338.30 30.87 8266.28 6804.97 21.47 14421.68 10724.32 34.48
Other Income 70.80 75.80 -6.60 158.54 134.06 18.26 303.86 418.48 -27.39
PBIDT 715.80 2.70 26411.11 1205.53 144.05 736.88 813.05 -510.65 -259.22
Interest 18.20 38.20 -52.36 32.02 62.95 -49.13 104.20 93.80 11.09
PBDT 697.60 -35.50 -2065.07 1173.51 81.10 1346.99 132.77 -1731.09 -107.67
Depreciation 263.90 272.60 -3.19 524.97 546.23 -3.89 1054.58 1059.79 -0.49
PBT 433.70 -308.10 -240.77 648.54 -465.13 -239.43 -921.81 -2790.88 -66.97
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 206.12 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 206.12 0.00
PAT 433.70 -308.10 -240.77 648.54 -465.13 -239.43 -921.81 -2997.00 -69.24
Equity 140.80 140.80 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 16.38 0.08 20152.66 14.58 2.12 588.95 5.64 -4.76 -218.40

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×